Royal Bank of Canada’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $81.5M | Sell |
|
|||||
|
2025
Q2 | $79.8M | Sell |
|
|||||
|
2025
Q1 | $97.8M | Sell |
|
|||||
|
2024
Q4 | $159M | Sell |
|
|||||
|
2024
Q3 | $214M | Buy |
|
|||||
|
2024
Q2 | $175M | Sell |
|
|||||
|
2024
Q1 | $181M | Buy |
|
|||||
|
2023
Q4 | $158M | Sell |
|
|||||
|
2023
Q3 | $147M | Sell |
|
|||||
|
2023
Q2 | $165M | Sell |
|
|||||
|
2023
Q1 | $235M | Sell |
|
|||||
|
2022
Q4 | $240M | Buy |
|
|||||
|
2022
Q3 | $200M | Buy |
|
|||||
|
2022
Q2 | $200M | Buy |
|
|||||
|
2022
Q1 | $166M | Sell |
|
|||||
|
2021
Q4 | $205M | Buy |
|
|||||
|
2021
Q3 | $215M | Buy |
|
|||||
|
2021
Q2 | $169M | Sell |
|
|||||
|
2021
Q1 | $181M | Sell |
|
|||||
|
2020
Q4 | $193M | Buy |
|
|||||
|
2020
Q3 | $157M | Sell |
|
|||||
|
2020
Q2 | $169M | Buy |
|
|||||
|
2020
Q1 | $66.2M | Sell |
|
|||||
|
2019
Q4 | $75.9M | Sell |
|
|||||
|
2019
Q3 | $69M | Sell |
|
|||||
|
2019
Q2 | $81.4M | Sell |
|
|||||
|
2019
Q1 | $88.9M | Buy |
|
|||||
|
2018
Q4 | $74.3M | Sell |
|
|||||
|
2018
Q3 | $94.1M | Sell |
|
|||||
|
2018
Q2 | $89.1M | Sell |
|
|||||
|
2018
Q1 | $95.9M | Buy |
|
|||||
|
2017
Q4 | $93M | Sell |
|
|||||
|
2017
Q3 | $129M | Buy |
|
|||||
|
2017
Q2 | $118M | Sell |
|
|||||
|
2017
Q1 | $126M | Buy |
|
|||||
|
2016
Q4 | $91.5M | Buy |
|
|||||
|
2016
Q3 | $63M | Buy |
|
|||||
|
2016
Q2 | $44.1M | Buy |
|
|||||
|
2016
Q1 | $41.8M | Sell |
|
|||||
|
2015
Q4 | $61.7M | Buy |
|
|||||
|
2015
Q3 | $51.2M | Sell |
|
|||||
|
2015
Q2 | $63.7M | Buy |
|
|||||
|
2015
Q1 | $54M | Buy |
|
|||||
|
2014
Q4 | $45.2M | Sell |
|
|||||
|
2014
Q3 | $42.4M | Buy |
|
|||||
|
2014
Q2 | $29.3M | Buy |
|
|||||
|
2014
Q1 | $22.7M | Sell |
|
|||||
|
2013
Q4 | $27.5M | Buy |
|
|||||
|
2013
Q3 | $15.7M | Buy |
|
|||||
|
2013
Q2 | $10.6M | Buy |
|